Bernstein reiterated coverage on Abbott Labs with a new price target

4/20/23 9:56:20 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Bernstein reiterated coverage of Abbott Labs with a rating of Outperform and set a new price target of $133.00 from $132.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ABT

Date	Price Target	Rating	Analyst
6/16/2025	$143.00	Market Perform	Leerink Partners
10/8/2024	$130.00	Outperform	Oppenheimer
9/19/2024	$131.00	Overweight	Piper Sandler
7/30/2024		Buy → Hold	Edward Jones
5/30/2024	$121.00	Buy	Goldman
7/21/2023		Underperform → Peer Perform	Wolfe Research
5/30/2023	$112.00	Overweight → Equal-Weight	Morgan Stanley
4/20/2023	$125.00 → $127.00	Overweight	Barclays